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Abstract
Autosomal dominant non-syndromic hearing loss (AD-NSHL) is one of the most common genetic diseases in human and is
well-known for the considerable genetic heterogeneity. In this study, we utilized whole exome sequencing (WES) and
linkage analysis for direct genetic diagnosis in AD-NSHL. The Korean family had typical AD-NSHL running over 6 generations.
Linkage analysis was performed by using genome-wide single nucleotide polymorphism (SNP) chip and pinpointed a
genomic region on 5q31 with a significant linkage signal. Sequential filtering of variants obtained from WES, application of
the linkage region, bioinformatic analyses, and Sanger sequencing validation identified a novel missense mutation
Arg326Lys (c.977G.A) in the POU homeodomain of the POU4F3 gene as the candidate disease-causing mutation in the
family. POU4F3 is a known disease gene causing AD-HSLH (DFNA15) described in 5 unrelated families until now each with a
unique mutation. Arg326Lys was the first missense mutation affecting the 3rd alpha helix of the POU homeodomain
harboring a bipartite nuclear localization signal sequence. The phenotype findings in our family further supported
previously noted intrafamilial and interfamilial variability of DFNA15. This study demonstrated that WES in combination with
linkage analysis utilizing bi-allelic SNP markers successfully identified the disease locus and causative mutation in AD-NSHL.
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Introduction
Hearing loss is one of the most common hereditary diseases
in human, and more than 70% of the cases are nonsyndromic
(NSHL) [1,2]. Most postlingual (late-onset) NSHL have an
autosomal dominant pattern of inheritance (AD-NSHL), while
prelingual (early-onset) NSHL is typically autosomal recessive
(AR-NSHL) [3]. AD-NSHL represents one of the examples of
extreme genetic heterogeneity in human with a growing list of
causative genes particularly by virtue of the recent advances in
genomics technology [4,5]. A total of 27 genes from 64 loci
(DFNA 1–64) and 41 genes from 95 loci and (DFNB1–95) have
been identified for AD-NSHL and AR-NSHL, respectively
(Hereditary Hearing Loss website; http://hereditaryhearingloss.
org; last access in May 2013), which poses a big challenge to
direct molecular genetic diagnosis of NSHL by conventional
targeted gene analyses.
Linkage analysis is one of the powerful approaches for the
identification of disease-causing genes, and single nucleotide
polymorphisms (SNPs), typically bi-allelic markers, have advan-
tages in its abundance in the human genome and ease of typing
with a high throughput. Recent advances in sequencing
technologies have enabled us to capture variants on a whole-
exome or whole-genome scale. In particular, sequencing of the
whole exome (whole exome sequencing [WES]) of selected
individuals in an affected pedigree holds a promise for disease
gene discovery in Mendelian disorders [6,7]. However, the
abundance of variants across genome or exome makes the
selection of ‘‘disease-causing’’ mutations still challenging. Thus,
narrowing down the genomic area in linkage with the disease
significantly increases the power of WES in disease mutation
identification.
In this study, we investigated on the deafness mutation in a
large Korean family with AD-NSHL by a combination
approach of linkage analysis using SNP chip and WES. As a
result, we successfully identified a novel mutation in DFNA15 in
the family.
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Materials and Methods
Ethics Statement
Written informed consent was obtained from all participating
individuals, and the study protocol was approved by the
institutional review board at the Samsung Medical Center, Seoul,
Korea.
Proband and Audiometric Analyses
The proband (IV-20) was a 45-year-old Korean woman with
NSHL since 21 years of age. Her family history revealed NSHL
with an autosomal dominant inheritance. The molecular genetic
test for the GJB2 gene revealed no mutations. Audiometric
analyses were performed in the proband and participating family
members. In particular, pure tone audiograms (PTA) were
obtained in each individual to determine hearing thresholds levels
(dB) of air and bone conduction at frequencies ranging from 250 to
8,000 Hz on right and left ears independently, according to the
standard protocols. Peripheral blood samples were collected from
the proband and family members participating in the genetic
diagnosis with given written informed consent.
SNP Genotyping and Linkage Analysis
Genome-wide SNP genotyping was performed on DNA
samples from 21 family members including the proband for
linkage analysis (11 were affected and 10 were unaffected). The
Illumina’s Linkage IV B Genetic Map v2 RevD panel was used for
genome-wide SNP scanning (Illumina Inc. San Diego, CA, USA).
This panel includes 6,008 SNP markers distributed evenly across
the genome. The genetic map position of each SNP in the panel
was determined by linear interpolation using NCBI build
35physical map position and a high-resolution STR genetic
deCODE map. The mean and median intervals between markers
were 488 Kb (0.62 cM) and 315 Kb (0.38 cM), respectively. Prior
to genotyping, the yields of pure double strand genomic DNA
samples were determined by using the Quant-iTTM PicoGreenH
dsDNA Assay Kit (Eugene, Oregon, USA). Samples were then
normalized to 50 ng/ul. Genotyping reactions were performed
using Illumina Bead-Station kit reagents and protocols. The
normalized genomic DNA (5 ul) from each sample was used as a
template for Illumina GoldengateH Genotype Assays. SNP arrays
were scanned using Illumina BeadArray Reader (Illumina Inc. San
Diego, CA, USA) under the Illumina BeadStation 500G system
version 2.3. For linkage analysis, we first excluded SNPs with a
Mendelian inheritance error by using PedCheck 1.1 [8]. The
Hardy-Weinberg equilibrium (HWE) test (P-value,0.01) was
performed by using PEDSTATS 0.6.3 [9]. Linkage scores were
calculated by MERLIN 1.1.2 [10]. Both muti-point parametric
and nonparametric analyses were performed to yield LOD sores
and NPL Z scores, respectively. In the parametric analysis, the
disease allele frequency was set to 0.0001% and penetrance with 0,
1 and 2 copies of the disease allele was set to 0.01%, 100% and
100%, respectively. Haplotypes of the region of interest (peak
linkage score) in the family were reconstructed by using PHASE
2.1.1 [11].
Whole Exome Sequencing
Four individuals in the family were selected for WES (3 affected
including family member and 1 unaffected; IV:3, IV:17, V:1 and
V:5 in the pedigree Figure 1A). The 64 million bases of exome
were targeted by NimbleGen SeqCap EZ Human Exome Library
v3.0 and sequenced by Illumina HiSeq. The 101-base-pair
sequence reads were mapped to UCSC hg19 reference genome
by using the Burrows-Wheeler Aligner [12]. Single nucleotide
variants and insertion-deletion variants were detected by the
SAMtools [13].
Sanger Sequencing Validation and Bioinformatic
Analyses
We performed Sanger sequencing for candidate variants from
WES in 4 individuals (IV:3, IV:17, V:1 and V:5) and also in the
remaining family members as indicated. Functional prediction,
conservation and allele frequency in the 1000 Genomes Project
and the Exome Sequencing Project 6500 data of missense variants
were annotated using dbNSFP [14]. Functional effects of missense
variants were predicted by five different programs, SIFT,
PolyPhen-2, LRT, MutationTaster and MutationAssesor. In
addition, sequence conservation of candidate variants was
estimated by Genomic Evolutionary Rate Profiling++ (GERP)
Rejected Substitution and conservation based on 29 mammals
genomes. For molecular modeling, we used the structure of
POU3F1 (2xsd) as a template to build a homology model for
POU4F3 because the 3D-structure of POU4F3 is not yet
experimentally solved. Modeling and subsequent analysis were
done using an automatic script in the YASARA & WHAT IF
Twinset with standard parameters [15,16]. The effect of the
mutation on the protein stability was estimated using the FoldX
plugin in YASARA [16]. Control studies were performed by
screening variants of interest involving DNA samples from 50
control individuals of Korean descent aged .60 years who had
normal hearing by PTA.
Results
Proband and Pedigree
The detailed family history revealed a pedigree of a large
Korean family (6 generations) with NSHL indicating the pattern of
autosomal dominant inheritance (Figure 1A and Table S1). The
age of onset of hearing loss in affected individuals ranged from
early 10 s to late 50 s. No individual with hearing loss had
syndromic features. PTA was obtained from 4 affected individuals
including the proband (IV-9, IV-13, IV-16 and IV-20) in the
family, which demonstrated bilateral minimal to moderate
sensorineural hearing loss with flat to gently downward-sloping
audiograms (Figure 1B). Peripheral blood samples were collected
from total 34 individuals including the proband (indicated with an
asterisk on the right shoulder of the symbols in Figure 1A).
Linkage Analysis
Total 215 SNPs were excluded from linkage analyses due to
Mendelian inheritance error. No markers failed the HWE test.
The NPL analysis revealed 4 genomic loci with an NPL Z score
.3. On parametric linkage analysis, we first obtained the LOD
score without including 4 individuals in the generation VI (VI:3,
VI:4, VI:6 and VI:7) whose affected status was ambiguous due to
the young age. As a result, a high LOD score (2.387) was observed
in the genomic region of 5q31, while the other 3 loci with NPL Z
score .3 demonstrated no significant LOD score (Table 1). For
those young 4 individuals (VI:3, VI:4, VI:6 and VI:7), we
performed a simulation study by labeling them as unaffected or
affected. The results showed that the LOD score was further
increased to 3.006 when they were assigned as ‘‘unaffected’’, while
the score decreased to 2.408 when they were assigned as
‘‘unknown phenotype’’. The LOD score was ,1 (loss of linkage
signal) when at least one individual among them was set as
‘‘affected’’. The haplotypes reconstructed from 26 SNPs with an
NPL Z score .3 revealed a single haplotype (#2) segregating with
the hearing loss phenotype in the family (Table S2), including
Linkage and Exome Analyses for Diagnosis of DFNA15
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Figure 1. A large Korean family with autosomal dominant late-onset nonsyndromic hearing loss. (A) The pedigree with the proband (IV-
20) indicated by an arrow. Individuals who participated in the molecular genetic diagnosis are marked with an asterisk on the right shoulder of
symbols. Whole exome sequencing was performed in 4 individuals (IV:3, IV:17, V:1 and V:5). The genotypes at theArg326Lys mutation site of
POU4F3are presented for each individual (mutant allele ‘‘A’’ in red). (B) Audiograms of 4 affected individuals in the family including the proband.
doi:10.1371/journal.pone.0079063.g001
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individuals VI:3, VI:4, VI:6 and VI:7 whose haplotypes were
assigned as ‘‘unaffected’’.
Whole Exome Sequencing and Mutation Identification
We obtained 84.3%290.6% of the target exome with coverage
of at least 10 sequence reads. A total of 153,611variants were
discovered in 4 individuals (IV:3, IV:17, V:1 and V:5), and
123,135 variants thereof passed the standard variant quality
control (QC). Among the passed variants, 3,395 were shown to be
compatible with the phenotype filter (all 3 affected individuals
were heterozygous for variants, while the other control individual
was homozygous for the reference genotypes) (Table S1). Among
those 3,395 variants, 21 non-synonymous SNPs were coincided
with the region of the linkage peak on 5q31, and 5 of them had an
allele frequency of ,1% on the variation data from the 1000
Genomes Project and Exome Sequencing Project 6500 (Table
S3). Among the 5 rare variants, a missense variation Arg326Lys
(c.977G.A) was occurring in the POU4F3 gene (POU domain,
class 4, transcription factor 3; MIM# 602460), a previously known
gene causing AD-NSHL (DFNA15). The affected Arg326 residue
was shown to be evolutionarily conserved across species, and the
missense change Arg326Lys was predicted to be deleterious by all
5 algorithms for functional prediction (Table 2). On the other
hand, 4 missense variants in other genes were predicted to be
benign. Sanger sequencing confirmed the WES findings in all 4
individuals (3 affected individuals were heterozygous for
Arg326Lys [G/A] and 1 unaffected individual was homozygous
for the reference genotype [G/G]). The sequencing analyses
targeting Arg326 of POU4F3 in other family members confirmed
that the mutant genotype was running together with the risk
haplotype and was completely segregating with the disease
phenotype (Figure 1A). The molecular modeling analyses
demonstrated that the Arg326Lys mutation was predicted to
destabilize the 3rd alpha-helix structure of the POU homeodomain
of the protein and thereby reduce the proper protein-DNA
interactions (Figures 2A and 2B). Lastly, the Arg326Lys variant
was not observed in a control population aged .60 years with
normal hearing (0/100 control chromosomes).
Discussion
The diagnosis of AD-NSHL is typically made based on the
phenotype and the inheritance pattern within the family affected,
and direct identification of the genetic background is not feasible
due to the large number of disease genes/DNFA loci. In this study,
we demonstrated that the molecular genetic diagnosis was
successful in a large Korean family with DFNA by utilizing a
combination approach of linkage analysis using genome-wide SNP
markers and WES. The linkage analyses uncovered a 27.1 Mb
region on the 5q31 band, which is one of the most gene-rich
genomic segments in human, and several known disease loci
(genes) have been previously identified on 5q31 in linkage with
hereditary HL including DFNA1 (DIAPH1), DFNA15 (POU4F3),
DFNA42, and DFNA54 [17–19]. Sequential filtering of the large
Table 1. Chromosome regions with nonparametric linkage Z score (NPL Z).3.0.
Chromosome
region Peak SNP
Position
(cM)a
Position
(Mb) NPL Z LODb Peak region (cM) Peak region (Mb, hg18)
5p13,p14 rs2034586 48.70 30.08 3.66 28.99 16.38260.61 6.12238.07
5q31 rs1016344 136.60 134.60 3.66 3.01 135.862152.10
(135.862165.02)c
133.442148.71
(133.442160.43)c
10p15 rs713588 17.89 5.93 3.58 29.27 4.44232.09 1.96213.10
12q22,q23 rs1030048 108.27 96.16 3.73 25.98 103.492112.36 92.21299.96
aGenetic distance from the p-terminus according to the deCODE high-resolution map.
bScores obtained on simulation analyses yielding the maximum value on 5q31 (see text for detail).
cThe peak region of 5q31 in parenthesis means the interval corresponding to the region with LOD .3.0.
doi:10.1371/journal.pone.0079063.t001
Figure 2. Molecular modeling of the POU4F3 protein constructed by the 2xsd protein as the template. (A) Overview of the modeled
POU4F3 domain. The protein chain is shown in grey using a ribbon representation, the position of the mutated residue is indicated in green, the DNA
is shown as a ball-and-stick model and colored yellow. (B) A close-up view of the mutated residue. The side chains of the wild-type and the mutant
residue are shown in green and red, respectively. The figures show that the wild-type Arginine residue interacts with the phosphate backbone of the
DNA, while the mutant Lysine residue is slightly shorter than Arginine and cannot make the same interactions with DNA.
doi:10.1371/journal.pone.0079063.g002
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number of variants obtained from WES pinpointed a missense
variant Arg326Lys in POU4F3 on 5q31, a previously known
NSHL gene, as a strong candidate (Table 2). The variant was
running with the risk haplotype ht-2 reconstructed from SNPs with
high LOD scores from linkage analysis (Figure 1). Based on the
further evidence from Sanger sequencing and bioinformatic
analyses, we concluded that Arg326Lys of POU4F3 on 5q31 was
the candidate causative mutation. On molecular modeling
analysis, the missense mutation was predicted to result in a
deficiency in the proper protein-DNA interaction of the protein by
destabilizing the 3rd alpha helix of the POU homeodomain.
The POU4F3 (POU domain, class 4, transcription factor 3) gene
on 5q31 (DFNA15) is one of the two genes belonging to the
superfamily of POU domain transcription factors that cause
NSHL, along with POU3F4 on Xq21.1 (DFN3). It was first
identified as a causative gene of AD-NSHL in a large Israeli Jewish
family by linkage analysis [19]. POU4F3 was an excellent
candidate gene because targeted deletion of both Pou5f3 alleles
in mice had been reported to result in complete deafness [20,21].
Indeed, the POU4F3 protein is a member of the POU family
transcription factors and is critical for the maintenance of inner ear
hair cells. Following the first report, 4 additional families with
NSHL from POU4F3 mutations have been reported in the
literature (Table 3) [22]. Collin et al. reported a missense
mutation (c.865C.T, p.Leu289Phe) in a large Dutch family by
linkage study using short tandem repeat (STR) markers and
candidate gene sequencing [23]. They additionally found another
family with DFNA15 from a different mutation (c.668T.C,
p.Leu223Pro) by screening 30 unrelated families by targeted
sequencing of POU4F3. The other 2 patients with DFNA15 were
Korean families. By screening for DFNA15 in 42 unrelated
Korean families with AD-NSHL by sequencing analyses of
POU4F3, Lee et al. uncovered a family with a frameshift mutation
by deletion of 14 nucleotides (c.662_675del14, p.Gly221Glufs*77)
[24]. Another Korean family with DFNA15 from a missense
mutation in POU4F3 (c.694G.A, p.Glu232Lys) was reported by
targeted massive parallel sequencing of 80 genes [25]. The
POU4F3 protein has 2 DNA binding domains, POU-specific
domain and POU homeodomain. In particular, the POU
homeodomain contains 2 functional nuclear localization signal
sequences, monopartite (amino acids 274–278) and bipartite
(amino acids 314–331 forming the 3rd alpha helix) [26]. The
missense mutations Leu223Pro and Glu232Lys affected the POU-
specific domain. Following the previously reported mutation
Table 2. Five rare missense mutations in the 5q31 linkage region.
Chr
Position
(bp, hg19)
Reference
allele
Mutant
allele
Reference
aa
Mutant
aa Gene
Functional
predictiona
GERP+
+RSb
29way
logOddsc
1000G
ALL_AF
1000G
ASN_AF
ESP
AA_AF
ESP
EA_AF
5 145719967 G A R K POU4F3 +++++ 4.62 16.40 0 0 0 0
5 140222014 G A A T PCDHA8 ++––– 2.66 12.17 0 0 0 0
5 139189261 A G N S PSD2 –+––– 3.99 9.55 0.0005 0.0017 0 0.0001
5 137548913 C T R Q CDC23 ––––– 4.13 9.63 0 0 0 0
5 140557626 G A S N PCDHB8 ––U –– 0.10 2.27 0.0014 0.0052 0 0
Abbreviations: Chr, chromosome; aa, amino acid; ALL, all populations; AF, allele frequency; ASN, Asian; AA, African American; EA, European American.
aFunctional effects predicted by SIFT, PolyPhen-2, LRT, MutationTaster and MutationAssesor in order. Deleterious effect was denoted as+, neutral effect as –, and
unpredicted effect as U.
bGenomic Evolutionary Rate Profiling++ Rejected Substitution score. The larger the score, the more conserved the site.
cConservation score is calculated based on 29 mammals genomes. The larger the score, the more conserved the site.
doi:10.1371/journal.pone.0079063.t002
Table 3. Genetics and phenotypes of DFNA15 in previously reported 5 families and in the Korean family in this report.
No. Ethnicity Methods Mutation Domain Phenotype Reference
1 Israeli
Jewish
Linkage analysis using STR markers
and candidate sequencing
c.884_891del8
(p.Ile295Thrfs*5)
NA 18–30 y; progressive; flat to
downward-sloping AC
Vahara et al.
1998 (19)
2 Dutch Linkage analysis using STR markers
and candidate sequencing
c.865C.T
(p.Leu289Phe)
POU homeodomain
(1st alpha-helix)
13 y–20; progressive; flat to gently
downward-sloping AC; vestibular
hypofunction +/2
Collin et al.
2008 (23),
Pauw et al.
2008 (28)
3 Dutch? Targeted sequencing of POU4F3
in 30 URF
c.668T.C
(p.Leu223Pro)
POU-specific domain 40 y; moderate to severe; affecting
mainly high frequencies
Collin et al.
2008 (23)
4 Korean Targeted sequencing of POU4F3
in 42 URF
c.662_675del14
(p.Gly221Glufs*77)
NA 20 y; severe; downward-sloping AC Lee et al. 2010
(13)
5 Korean Targeted massively parallel
sequencing of 80 genes and
Sanger validation in 8 URF
c.694G.A
(p.Glu232Lys)
POU-specific domain 27/28 y; moderate/severe; flat/
downward-sloping AC
Baek et al.
2012 (25)
6 Korean Linkage analysis using SNP markers
and Sanger validation
c.977G.A
(p.Arg326Lys)
POU homeodomain
(3rd alpha-helix)
Early 10 s-late 50 s; mild to
moderate flat to gently
downward-sloping AC
Kim et al. This
report
NA, not applicable; y, years of age; AC, audiometric configuration; URF, unrelated families.
doi:10.1371/journal.pone.0079063.t003
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Leu289Phe, Arg326Lys identified in our patient was the 2nd
missense mutation in the POU homeodomain. Of note,
Leu289Phe was located in the 1st alpha-helix, and Arg326Lys
was the first missense mutation affecting the 3rd alpha-helix of the
POU homeodomain, which has the bipartite nuclear localization
signal. In line with our observations from molecular modeling
analyses, a previous bioinformatic study on the missense mutation
affecting the Arg329 residue of POU3F4 (Arg329Pro), which
corresponds to the Arg325 residue of POU4F3 mutated in our
family, demonstrated a detrimental functional consequence of the
mutation on the 3rd alpha helix structure [27]. The precise
molecular pathophysiological mechanisms would be different
between POU3F4- and POU4F3- related deafness in speculation
of the different modes of inheritance (X-linked recessive vs
autosomal dominant, respectively) [27]. Collectively, the
Arg326Lys mutation of POU4F3 in our family was predicted to
exert its mutational effects by a combination of defects in the
stability of its tertiary structure, DNA binding ability, transcrip-
tional activity, and the nuclear localization of the protein. As for
the genotype-phenotype correlations in DFNA15, the evidence
collected from previously reported 5 families, albeit limited in
number, have demonstrated late-onset bilateral progressive
hearing loss with significant intra- and interfamilial variabilities
in terms of the age of onset and severity of disease and the
configuration of audiometric findings (Table 3) [19,23–25,28]. In
line with this observation, the family in this report also
demonstrated a wide range of onset of hearing loss (early 10 s to
late 50 s). The audiograms obtained from 4 affected individuals
also showed sensorineural hearing loss with an intrafamilial
variability (Figure 1B). Further investigation is needed to
delineate the precise molecular pathophysiological consequence
of this variant in the hearing function.
Recently, the identification of disease-causing genes and
mutations has been accelerated by the unprecedented advances
and growing availability of genome research technologies includ-
ing massively parallel sequencing. However, how to select and
determine which variant (s) is (are) the disease-causing mutation (s)
in the patient/family under investigation is a big challenge due to
the large number of variants obtained from genome or exome
sequencing. In order to cope with this challenge, linkage
information is critically useful to narrow down the disease locus
and thereby to decrease the number of candidate variants, utilizing
identity-by-descent information [29]. In the field of hearing
genetics, there also have been reports on novel disease genes
and mutations by utilizing WES. As in other disease entities, the
application of WES is more robust in AR-NSHL (DFNB)
especially in consanguineous families with or without homozygos-
ity mapping by SNP-array [30–32]. On the other hand, the
determination of disease-causing gene/mutation is more challeng-
ing in AD-NSHL, and a couple of recent studies reported on
successful identification of novel mutations in known DFNA genes
[33,34]. In particular, the study by Park et al. on DFNA20/26
(ACTG1 mutation) pinpointed the causative mutation from the list
of variants obtained from WES utilizing linkage information from
SNP markers as in our study [34]. Also in our family, we could
decrease the number of functional candidate variants from 444
(genomewide) to 21 by applying the linkage region (5q31) (Table
S3). Collectively, it is anticipated that WES in combination of
linkage information can be successfully utilized in elucidating the
genetic background of AD-NSHL. It should also be noted that the
technical success and growing availability of genome tests also
bring up issues of carrier detection by family study and informed
genetic counseling. As in presymptomatic minors carrying the
POU4F3 mutation in our family, for example, a careful approach
is mandatory for pre-test and post-test counseling in late-onset
diseases such as DFNA [35].
In conclusion, this study demonstrated that WES in combina-
tion with linkage analysis using bi-allelic SNP markers successfully
identified the candidate locus and mutation in AD-NSHL. The
POU4F3 mutation identified in the Korean family was the first
missense mutation affecting the 3rd alpha helix of the POU
homeodomain harboring a bipartite nuclear localization signal of
the protein. We believe the growing availability of molecular
genomic tests opens the possibility of better understanding of
molecular mechanisms and genotype-phenotype correlations in
NSHL.
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